<?xml version="1.0" encoding="UTF-8" ?><rss version="2.0">
<channel>
<title>American Journal of Drug Discovery and Development - Current Issue</title>
<link>https://scialert.net</link>
<description>American Journal of Drug Discovery and Development</description>
<language>en-us</language>
<copyright>Science Alert</copyright>
<pubDate>Thu, 11 Jun 2026 18:11:57 +0200</pubDate>
<lastBuildDate>Thu, 11 Jun 2026 18:14:14 +0200</lastBuildDate>
<generator>RssPublisher 0.2.0 beta</generator>
<image>
<url>https://scialert.net/images/logo.gif</url>
<title>American Journal of Drug Discovery and Development - Current Issue</title>
<link>https://scialert.net</link>
<height>41</height>
<width>233</width>
<description>American Journal of Drug Discovery and Development</description>
</image>
<item>
Leptadenia hastata Pers. (Decne) a Promising Source for Natural
Compounds in Biomedical Applications<title><![CDATA[Leptadenia hastata Pers. (Decne) a Promising Source for Natural
Compounds in Biomedical Applications]]></title> 
<description><![CDATA[<i>Leptadenia hastata</i> (Pers) Decne. of Apocynaceae family is an African plant which is used as nutriment as well as for medical purposes
due to its health promoting properties. Traditional healers use <i>L. hastata</i> to treat many diseases as hypertension, sexual impotence,
trypanosomosis, acute rhinopharyngitis. In quantitative and qualitative terms, the leaves of <i>L. hastata</i> contain significant quantities of
secondary metabolites, as triterpenes, total flavonoids, tanins, which can be important in biomedical research. <i>In vivo</i> studies showed
the antifertility effect of <i>L. hastata</i> leaves extracts which can be useful for hormonal therapy replacement. Herein, the ecology, traditional
medicinal uses, phytochemistry, toxicity and pharmacology of L. hastata in consideration of its antifertility activity is reviewed. In view
of its constituents such as steroidal glycosides, triterpenes and polyoxypregnane derivatives, further investigation on the effect of
<i>L. hastata</i> on other hormonal endpoints like hormone dependent cancers appears promising.]]></description>
<link>https://scialert.net/abstract/?doi=ajdd.2018.1.10</link> 
<pubDate>11 June, 2026</pubDate>
</item>
</channel>
</rss>